Thrombosis
News
Dicloxacillin may cut INR levels in warfarin users
The antibiotic dicloxacillin appears to markedly decrease INR levels in patients taking warfarin.
News
Bivalirudin in STEMI has low real-world stent thrombosis rate
Key clinical point: The 30-day incidence of stent thrombosis following primary PCI in a large, real-world STEMI population was reassuringly low...
Conference Coverage
Routine screening sufficient for detecting occult cancer in patients with VTE
Key clinical point: Occult cancers in patients with a first unprovoked VTE are not nearly as common as previously thought, and limited screening...
Conference Coverage
In PCI, switching clopidogrel nonresponders to prasugrel halved 2-year cardiac mortality
Switch clopidogrel nonresponders undergoing percutaneous coronary intervention to prasugrel to cut their 2-year cardiac mortality risk in half.
Conference Coverage
Risk of major bleeding is decreased when AF patients do not receive bridging anticoagulation
Key clinical point: Forgoing bridging anticoagulation in patients with atrial fibrillation is noninferior to perioperative bridging for preventing...
Conference Coverage
High VTE recurrence risk persists for at least 3 years
The risk of recurrence following an initial episode of venous thromboembolism is highest in the first 3 months, but remains high for up to 3 years...
Conference Coverage
Statins showed no benefit in reducing risk of recurrent VTE
The use of statins showed no benefit in reducing the risk of recurrent venous thromboembolism in patients enrolled in phase III trials comparing...
News
Extended warfarin delays return of unprovoked pulmonary embolism
Key clinical point: Eighteen additional months of warfarin therapy delays the recurrence of unprovoked pulmonary embolism. Major finding: During...
Conference Coverage
Idarucizumab reverses dabigatran’s anticoagulant effects
Key clinical point: The investigational monoclonal antibody idarucizumab reversed the anticoagulant effects of dabigatran. Major finding:...
Conference Coverage
New tools aid decisions on length of dual-antiplatelet therapy
Key clinical point: Stent location and CRUSADE score can inform decisions about the duration of dual-antiplatelet therapy. Major finding: Coronary...
News
‘Modest’ uptake of novel anticoagulants in real-world practice
Key clinical point: Clinicians have only modestly adopted novel oral anticoagulants into real-world clinical practice. Major finding: Early...